Yt Tai | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Yt Tai is active.

Explore More

Publication

Featured researches published by Yt Tai.

Blood | 2002

LAQ824 is a novel histone deacetylase inhibitor with significant activity against multiple myeloma: Results of a pre-clinical evaluation in vitro and in vivo.

L Catley; Ellen Weisberg; Yt Tai; Boris Lin; Nicholas Mitsiades; Teru Hideshima; Richard LeBlanc; R Shringapure; Renate Burger; Constantine S. Mitsiades; D Chauhan; R. Schlossman; Nikhil C. Munshi; Paul G. Richardson; James D. Griffin; Kenneth C. Anderson

Journal of Clinical Oncology | 2006

Novel model to evaluate changes in gene expression profile of myeloma cells in vivo following interaction with human BM microenvironment.

Ep Neri; Pierfrancesco Tassone; Masood A. Shammas; Yt Tai; Simona Blotta; Rao Prabhala; L Catley; P Tagliaferri; Salvatore Venuta; Kenneth C. Anderson; Nc Munshi

Blood | 2005

Targeting Src-family kinase activation and downstream molecular events to overcome MM cell growth, survival, and drug-resistance.

Klaus Podar; Yt Tai; Dean Abtahi; Raab; Hiroshi Yasui; Kenji Ishitsuka; Norihiko Shiraishi; L Catley; Martin Sattler; Noopur Raje; Teru Hideshima; D Chauhan

Blood | 2003

Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications.

Reshma Shringarpure; D Chauhan; Renate Burger; L Catley; Yt Tai; Klaus Podar; Teru Hideshima; Nicholas Mitsiades; Constantine S. Mitsiades; Kenneth C. Anderson

Journal of Clinical Oncology | 2017

Participation of BTK in MYD88 signaling in malignant cells expressing the L265P mutation in Waldenstrom’s macroglobulinemia, and effect on tumor cells with BTK-inhibitor PCI-32765 in combination with MYD88 pathway inhibitors.

Guang Yang; Lian Xu; Yangsheng Zhou; Xia Liu; Yang Cao; Christina Tripsas; Christopher J. Patterson; Zachary R. Hunter; Yt Tai; Kenneth C. Anderson; Steven P. Treon

Journal of Clinical Oncology | 2016

Lenalidomide and bortezomib induce osteoclast cytotoxicity and decrease BAFF secretion in osteoclasts in human multiple myeloma: Clinical implications

I. Breitkreutz; Yt Tai; X. Li; R. Coffey; Marc S. Raab; W. Song; Teru Hideshima; D Chauhan; Nc Munshi; Kenneth C. Anderson

Journal of Clinical Oncology | 2016

Identification of specific immune responses in monoclonal gammopathy of undetermined significance with therapeutic implications

Simona Blotta; Constantine S. Mitsiades; Pierfrancesco Tassone; J. Negri; Yt Tai; Rao Prabhala; B. Franco; Salvatore Venuta; Kenneth C. Anderson; Nc Munshi

Blood | 2005

Proteasome inhibitor does not affect the function of human immune systems: Effects on dendritic cells, T lymphocytes and NK cells.

Je Bae; Yt Tai; T Hidesima; L Catley; Xiangen Li; Rao Prabhala; Rb Bachu; Robert C. Bertheau; Masood A. Shammas; S Samala; Justine D. Miller; Kenneth C. Anderson; Nc Munshi

Blood | 2005

Alkylphosphocholine perifosine inhibits myeloma cell growth while inducing myeloid hyperplasia in a marine myeloma model.

L Catley; Teru Hideshima; D Chauhan; Paola Neri; Pierfrancesco Tassone; Yt Tai; Weihua Song; Carrasco; Nc Munshi; Kenneth C. Anderson

Blood | 2004

A Novel Inosine Monophosphate Dehydrogenase Inhibitor VX-944 Overcomes Conventional Drug-Resistance in Multiple Mueloma Cells in the Bone Marrow Microenvironment.

Kenji Ishitsuka; Teru Hideshima; Makoto Hamasaki; Raje Noopur; Kumar Shaji; Hiroshi Yasui; Aldo M. Roccaro; Dharminder Chauhan; Klaus Podar; Yt Tai; Jugnu Jain; Kenneth C. Anderson

Explore More